Weight Gain in Infancy and Overweight or Obesity in Childhood across the Gestational Spectrum: a Prospective Birth

Guoying Wang1, Sara Johnson1,2, Yiwei Gong3

  • 1Department of Population, Family and Reproductive Health, Center on Early Life Origins of Disease, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA.

Scientific Reports
|July 16, 2016
PubMed

Insights

Rapid infant weight gain significantly increases childhood overweight or obesity (OWO) risk, especially for babies born prematurely. Monitoring infant weight gain from birth is crucial for preventing childhood obesity.

Area of Science:

  • Pediatrics
  • Child Health
  • Public Health

Background:

  • Childhood obesity is a growing public health concern.
  • Understanding early life factors influencing weight trajectories is essential for prevention.
  • Gestational age at birth may modify the impact of early weight gain on later outcomes.

Purpose of the Study:

  • To investigate the optimal degree of infant weight gain across the gestational spectrum.
  • To examine the association between infant weight gain patterns and childhood overweight or obesity (OWO).
  • To identify risks associated with different weight gain velocities in relation to gestational age.

Main Methods:

  • Longitudinal study of 1971 children from birth to 7 years.
  • Infant weight gain categorized into slow, on track, rapid, and extremely rapid based on z-scores.
  • Overweight or obesity (OWO) defined by body mass index percentiles for age and gender.

Main Results:

  • Overweight or obesity (OWO) prevalence was 39.7% in the study population.
  • Infant weight gain strongly tracked from 4 to 24 months and associated with OWO.
  • Extremely rapid weight gain significantly elevated OWO risk in early term and late preterm infants.

Conclusions:

  • Optimal infant weight gain monitoring from birth is key for primary prevention of childhood obesity.
  • Gestational age influences the risk of OWO associated with infant weight gain.
  • Targeted interventions may be needed for high-risk infants based on gestational age and weight gain patterns.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
332
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
351
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.7K